Sales & Marketing News | pharmaphorum

News

BMS, Pfizer take DTC route for blood thinner Eliquis

BMS, Pfizer launch direct-to-patient sales for anticoagulant Eliquis, as a report cites conflict-of-interest concerns about the emerging DTC channel.

News

GSK's growth plans dented by Blenrep setback

FDA advisors have voted that the benefit/risk profile of GSK's multiple myeloma therapy, Blenrep, does not support its approval in the US.

News

Colleagues discuss information on a laptop screen

EVERSANA unveils new AI-powered pharmacovigilance suite

EVERSANA has launched a new pharmacovigilance platform to answer the need for advanced analytics and AI in drug safety monitoring and risk management.

News

Bayer extends CEO contract amid 'signs of success'

Bayer's chief executive Bill Anderson looks set to keep his role until nearly the decade, as his turnaround plan starts to deliver results.

News

UK plan to lead life sciences gets mixed response

The UK has unveiled its plan to revitalise the life sciences sector and become a global leader by 2030, but a pharma trade group says it falls short.

News

LEO bulks up with deal for Boehringer skin drug

LEO Pharma has licensed a medicine for a rare form of psoriasis from Boehringer Ingelheim, plugging a gap in its near-term product portfolio.

BMS, Pfizer take DTC route for blood thinner Eliquis

GSK's growth plans dented by Blenrep setback

EVERSANA unveils new AI-powered pharmacovigilance suite

Bayer extends CEO contract amid 'signs of success'

UK plan to lead life sciences gets mixed response

LEO bulks up with deal for Boehringer skin drug

Lilly UK recruits ex-England cricketer as obesity champion

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks